- €445.67m
- €451.31m
- €262.43m
- 100
- 32
- 77
- 83
2019 December 31st | 2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 192 | 190 | 207 | 229 | 262 |
Cost of Revenue | |||||
Gross Profit | 121 | 125 | 139 | 154 | 181 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 174 | 173 | 184 | 206 | 235 |
Operating Profit | 17.5 | 17.1 | 23.1 | 23.5 | 27.3 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 27.5 | 16.9 | 22.8 | 23.2 | 26.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 24.1 | 13.8 | 18.3 | 18.5 | 21.6 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 24.1 | 13.8 | 18.3 | 18.7 | 21.6 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 24.1 | 13.8 | 18.3 | 18.7 | 21.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 3.74 | 2.16 | 2.9 | 2.84 | 3.29 |
Dividends per Share |